Donate
CanceRx - CanceRxCanceRxCanceRx

  • What Does CanceRx Do
  • About CanceRx
  • Clinical Trials
  • CanceRx Foundation
  • News & Media
  • Contact Us

Blog

Posted on July 18, 2023August 15, 2023

Pfizer Inks Potential $7B Deal with Flagship to Deepen Pipeline

Pfizer is looking to enrich its pipeline with up to 10 new innovative medicines by partnering with startup creator Flagship Pioneering, the companies announced Tuesday.

Under the terms of the agreement, Pfizer and Flagship will each contribute an upfront investment of $50 million. The collaboration will leverage Flagship’s rich ecosystem of biotechnology platforms and more than 40 human health companies.

Read More
Read More
Posted on June 14, 2023August 15, 2023

New results show vaccine could help fight brain cancer

Early results from an experimental vaccine for glioblastoma, a type of brain cancer, show the potential to delay recurrence and double life expectancy in patients. NBC News’ Anne Thompson speaks with a neurosurgeon, scientist and patient about the findings' potential impact.

Read More
Read More
Posted on June 14, 2022August 15, 2023

Harvard Business School Announces Its 2022-2023 Blavatnik Fellows

BOSTON—Harvard Business School (HBS) has named its 2022-23 Blavatnik Fellows and the program’s ninth cohort. Launched in 2013, the Blavatnik Fellowship in Life Science Entrepreneurship is part of a gift to Harvard University from the Blavatnik Family Foundation. This program supports HBS alumni and Harvard-affiliated postdocs as they build their promising life science ventures by developing their leadership talents and providing mentorship and community during their entrepreneurial journey.

Read More
Read More
Posted on June 10, 2022August 15, 2023

Eye-catching cancer drug trial results have researchers asking: What’s next?


After a small cancer drug study yielded the unprecedented result of 100 percent of participants entering remission, oncologists — and patients — wonder if the approach from the experimental drug trial can apply to other types of cancer.





The study out of Memorial Sloan Kettering Cancer Center in New York has oncologists excited over the prospect that immunotherapy, the treatment type used in the trial, has increasingly shown effectiveness — without surgery




Read More
Read More
Posted on December 15, 2021August 15, 2023

New blood test could change the way cancer is detected


GRAIL, a Silicon Valley startup, created the Galleri test, which can screen for more than 50 cancers by looking at blood for DNA shed by cancer tumors. If it sees that DNA, then it predicts where the cancer is. A positive result isn’t always accurate, but researchers at the National Cancer Institute say study results so far could potentially revolutionize cancer screening, and they’re designing bigger studies.




Read More
Read More
Posted on December 12, 2021August 15, 2023

50 years of the War on Cancer


It was 50 years ago this month that Richard Nixon announced the War on Cancer, providing funding for research and cures. NBC News’ Harry Smith reports on how that battle has progressed, and what lies ahead.




Read More
Read More
Posted on July 10, 2019August 15, 2023

Can Financial Engineering and Data Science Cure Cancer?


Innovation Spotlight presentation at Amazon re:MARS, filmed on June 6, 2019 at ARIA Resort & Casino in Las Vegas, NV. Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management and director of the MIT Laboratory for Financial Engineering.




View Video
Read More

Categories

  • Uncategorized 7

Recent Posts

  • Pfizer Inks Potential $7B Deal with Flagship to Deepen PipelineJuly 18, 2023
  • New results show vaccine could help fight brain cancerJune 14, 2023
  • Harvard Business School Announces Its 2022-2023 Blavatnik FellowsJune 14, 2022
  • Eye-catching cancer drug trial results have researchers asking: What’s next?June 10, 2022
  • New blood test could change the way cancer is detectedDecember 15, 2021

Archives

  • July 2023
  • June 2023
  • June 2022
  • December 2021
  • July 2019
CanceRx Foundation, Inc, is an IRS-approved tax-exempt charitable Foundation under §501(c)(3) of the Internal Revenue Code.
A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE (800-435- 7352) WITHIN THE STATE. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE.

 

 

4830 W Kennedy Blvd, Suite 600
Tampa, FL 33609

(813) 776-0000

donations@cancerx-foundation.org

Copyright © 2023 CanceRx. All rights reserved.